Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels

Table 3

Clinical outcomes.

	Before PS matching				After PS matching
Variable	de novo	≤ 2.75 mm	>2.75 mm	p-value	≤ 2.75 mm	>2.75 mm	p-value
Number of patients	686	552	134	-	117	117	-
Patients with clinical follow-up	604 (88.0%)	493 (89.3%)	111 (82.8%)	0.038	106 (90.6%)	99 (84.6%)	-
Follow-up time (months)	8.7±1.7	8.7±1.7	8.8±1.7	0.523	8.5±1.8	8.8±1.8	0.306
In hospital MACE	7 (1.2%)	4 (0.8%)	3 (2.7%)	0.093	1 (0.9%	3 (3.0%)	0.313
In hospital Re-PTCA	2 (0.3%)	1 (0.2%)	1 (0.9%)	0.247	0 (0.0%)	1 (0.9%)	0.316
In hospital CABG	0 (0.0%)	0 (0.0%)	0 (0.0%)	-	0 (0.0%)	0 (0.0%)	-
In hospital MI	5 (0.8%)	2 (0.4%)	3 (2.7%)	0.016	1 (0.9%)	3 (2.6%)	0.313
In hospital cardiac death	2 (0.3%)	1 (0.2%)	1 (0.9%)	0.247	0 (0.0%)	1 (0.9%)	0.316
Acute Thrombotic events
acute (<24h)	1 (0.2%)	0 (0.0%)	1 (1.1%)	0.082	0 (0.0%)	0 (0.0%)	-
subacute (>24h)	1 (0.2%)	1 (0.2%)	0 (0.0%)		0 (0.0%)	0 (0.0%)
9-month MACE	34 (5.6%)	27 (5.5%)	7 (6.3%)	0.732	6 (5.7%)	6 (6.1%)	0.903
9-month TLR	14 (2.3%)	12 (2.4%	2 (1.8%)	0.689	4 (3.8%)	1 (1.0%)	0.200
9-month Re-PTCA	10 (1.7%)	9 (1.8%)	1 (0.9%)	0.490	4 (3.8%)	1 (1.0%)	0.200
9-month CABG	5 (0.8%)	4 (0.8%)	1 (0.9%)	0.916	0 (0.0%)	0 (0.0%)	-
9-month MI	22 (3.6%)	17 (3.4%)	5 (4.5%)	0.592	3 (2.8%)	4 (4.0%)	0.624
9-month cardiac death	6 (1.0%)	3 (0.3%)	3 (2.7%)	0.044	0 (0.0%)	3 (3.0%)	0.071
9-month TVR	25 (4.1%)	20 (4.1%)	5 (4.5%)	0.831	8 (7.5%)	4 (4.0%)	0.285
9-month non-target vessel revascularization	14 (2.3%)	10 (2.0%)	4 (3.6%)	0.319	2 (1.9%)	3 (3.0%)	0.596
9-month vessel thrombosis	2 (0.3%)	1 (0.2%)	1 (0.9%)	0.247	0 (0.0%)	1 (1.0%)	0.300

DES thrombotic event distal of DCB lesion.
independent t-test, otherwise Chi² or Fisher’s Exact Test whenever applicable.